Advanced search
Start date
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

The renoprotective effects of Heme Oxygenase-1 during contrast-induced acute kidney injury in pre-clinical diabetic models

Full text
da Fonseca, Cassiane Dezoti [1, 2] ; Watanabe, Mirian [3] ; Fernandes Couto, Sheila Marques [2] ; Carneiro Dos Santos, Alef Aragao [4] ; Borges, Fernanda Teixeira [5, 4] ; Fernandes Vattimo, Maria de Fatima [2]
Total Authors: 6
[1] Univ Fed Sao Paulo, Escola Paulista Enfermagem, Sao Paulo, SP - Brazil
[2] Univ Sao Paulo, Lab Expt Modelos Anim LEMA, Escola Enfermagem, Sao Paulo, SP - Brazil
[3] Fac Metropolitanas Unidas FMU, Ctr Univ, Sao Paulo, SP - Brazil
[4] Univ Cruzeiro Sul, Programa Posgrad Interdisciplinar Ciencias Saude, Sao Paulo, SP - Brazil
[5] Univ Fed Sao Paulo, Div Nefrol, Sao Paulo, SP - Brazil
Total Affiliations: 5
Document type: Journal article
Source: Clinics; v. 76, 2021.
Web of Science Citations: 0

OBJECTIVES: Contrast-induced acute kidney injury (CI-AKI) is an important clinical problem that can be aggravated by diabetes mellitus, a major risk factor. However, heme oxygenase-1 (HO-1), a promising therapeutic target, can exert antioxidant effects against CI-AKI. Thus, we investigated the role of HO-1 in CI-AKI in the presence of diabetes mellitus. METHODS: Twenty-eight male Wistar rats weighing 250-300g were subjected to left uninephrectomy, and concomitantly, diabetes induced by streptozotocin (65 mg/kg). After 12 weeks, iodinated contrast (meglumine ioxithalamate, 6 mL/kg) and hemin (HO-1 inducer-10 mg/k) were administered 60 min before iodinated contrast treatment. The rats were randomly divided into four groups: control, diabetes mellitus (DM), DM iodinated contrast (DMIC), and DMIC hemin (DMICH). Kidney function, albuminuria, oxidative profile, and histology were assessed. All experimental data were subjected to statistical analyses. RESULTS: CI-AKI in preclinical diabetic models decreased creatinine clearance and increased urinary neutrophil gelatinase-associated lipocalin (NGAL) levels and the degree of albuminuria. Additionally, the levels of oxidative and nitrosative stress metabolites (urinary peroxides, thiobarbituric acid-reactive substances, and NO) were elevated, while thiol levels in kidney tissue were reduced. Kidney histology showed tubular cell vacuolization and edema. HO-1 inducer treatment improved kidney function and reduced urinary the NGAL levels. The oxidative profile showed an increase in the endogenous thiol-based antioxidant levels. Additionally, the tubular injury score was reduced following HO-1 treatment. CONCLUSIONS: Our findings highlight the renoprotective effects of HO-1 in CI-AKI and preclinical diabetic models. Therefore, HO-1 ameliorates kidney dysfunction, reduces oxidative stress, and prevents cell necrosis. (AU)

Grantee:Mirian Watanabe
Support Opportunities: Scholarships in Brazil - Post-Doctorate
FAPESP's process: 13/26560-2 - Iodinated contrast induced acute kidney injury in diabetic and nephropathy diabetic in rats
Grantee:Maria de Fatima Fernandes Vattimo
Support Opportunities: Regular Research Grants